José A. Gómez‐Puerta

6.6k total citations
154 papers, 3.3k citations indexed

About

José A. Gómez‐Puerta is a scholar working on Rheumatology, Immunology and Hematology. According to data from OpenAlex, José A. Gómez‐Puerta has authored 154 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 116 papers in Rheumatology, 41 papers in Immunology and 32 papers in Hematology. Recurrent topics in José A. Gómez‐Puerta's work include Systemic Lupus Erythematosus Research (79 papers), Rheumatoid Arthritis Research and Therapies (47 papers) and Monoclonal and Polyclonal Antibodies Research (21 papers). José A. Gómez‐Puerta is often cited by papers focused on Systemic Lupus Erythematosus Research (79 papers), Rheumatoid Arthritis Research and Therapies (47 papers) and Monoclonal and Polyclonal Antibodies Research (21 papers). José A. Gómez‐Puerta collaborates with scholars based in Spain, United States and Colombia. José A. Gómez‐Puerta's co-authors include Ricard Cervera, Gerard Espinosa, Manuel Ramos‐Casals, Silvia Bucciarelli, Josep Font, Raimón Sanmartí, Karen H. Costenbader, Xavier Bosch, Juan D. Cañete and M Ingelmo and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and Pharmacological Reviews.

In The Last Decade

José A. Gómez‐Puerta

138 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
José A. Gómez‐Puerta Spain	31	2.3k	820	810	504	441	154	3.3k
Jean‐Charles Piette France	19	2.5k 1.1×	775 0.9×	1.0k 1.3×	409 0.8×	462 1.0×	19	3.7k
Tadej Avčin Slovenia	32	1.6k 0.7×	974 1.2×	1.1k 1.4×	418 0.8×	434 1.0×	134	3.2k
Clarissa Pilkington United Kingdom	36	2.1k 0.9×	951 1.2×	473 0.6×	531 1.1×	498 1.1×	108	3.8k
J.C. Piette France	35	2.2k 0.9×	921 1.1×	1.1k 1.4×	648 1.3×	405 0.9×	145	4.4k
Murat İnanç Türkiye	28	1.6k 0.7×	746 0.9×	463 0.6×	635 1.3×	219 0.5×	134	2.9k
Olga Amengual Japan	28	2.0k 0.9×	648 0.8×	1.2k 1.5×	190 0.4×	328 0.7×	90	2.6k
Maria Gerosa Italy	31	1.5k 0.6×	712 0.9×	599 0.7×	168 0.3×	297 0.7×	105	2.3k
Xinping Tian China	27	1.6k 0.7×	774 0.9×	398 0.5×	699 1.4×	268 0.6×	214	2.8k
D. Lê Thi Huong France	35	2.2k 0.9×	893 1.1×	514 0.6×	1.2k 2.4×	441 1.0×	82	4.2k
Azzudin E. Gharavi United States	23	2.9k 1.2×	705 0.9×	1.4k 1.7×	226 0.4×	482 1.1×	36	3.5k

Countries citing papers authored by José A. Gómez‐Puerta

Since Specialization

Citations

This map shows the geographic impact of José A. Gómez‐Puerta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by José A. Gómez‐Puerta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites José A. Gómez‐Puerta more than expected).

Fields of papers citing papers by José A. Gómez‐Puerta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by José A. Gómez‐Puerta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by José A. Gómez‐Puerta. The network helps show where José A. Gómez‐Puerta may publish in the future.

Co-authorship network of co-authors of José A. Gómez‐Puerta

This figure shows the co-authorship network connecting the top 25 collaborators of José A. Gómez‐Puerta. A scholar is included among the top collaborators of José A. Gómez‐Puerta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with José A. Gómez‐Puerta. José A. Gómez‐Puerta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Arango, Claudia P., Andrés Ponce, Juan Camilo Sarmiento-Monroy, et al.. (2025). Clinical and Ultrasound Characteristics of a Difficult-to-Treat Psoriatic Arthritis Population. Diagnostics. 15(19). 2418–2418.

Ponce, Andrés, et al.. (2025). Ultrasound: a useful tool for diagnosing tibial stress fractures. Lara D. Veeken. 64(6). 4103–4104. 1 indexed citations

Andreu, José Luís, Rafael Cáliz, Hèctor Corominas, et al.. (2024). Actualización del Documento de Consenso de la Sociedad Española de Reumatología sobre el uso de terapias biológicas y sintéticas dirigidas en la artritis reumatoide. Reumatología Clínica. 20(8). 423–439.

Ponce, Andrés, Estíbaliz Ruiz‐Ortiz, María J. Gómara, et al.. (2024). Neutrophilic Activity Biomarkers (Plasma Neutrophil Extracellular Traps and Calprotectin) in Established Patients with Rheumatoid Arthritis Receiving Biological or JAK Inhibitors: A Clinical and Ultrasonographic Study. Rheumatology and Therapy. 11(3). 501–521. 3 indexed citations

Salman-Monte, Tarek Carlos, Javier Narváez, Alejandro Olivé, et al.. (2024). Satisfaction and effectiveness of switching from intravenous to subcutaneous belimumab treatment in daily clinical practice. Lupus. 33(5). 481–489. 1 indexed citations

Hernández‐González, Fernanda, Federico Pietrocola, Paolo Cameli, et al.. (2024). Exploring the Interplay between Cellular Senescence, Immunity, and Fibrosing Interstitial Lung Diseases: Challenges and Opportunities. International Journal of Molecular Sciences. 25(14). 7554–7554. 5 indexed citations

Sarmiento-Monroy, Juan Camilo, Andrés Ponce, José A. Gómez‐Puerta, et al.. (2024). Axial Disease in Psoriatic Arthritis: A Challenging Domain in Clinical Practice. Diagnostics. 14(15). 1637–1637.

Xipell, Marc, Gema M. Lledó, Allyson Egan, et al.. (2023). From systemic lupus erythematosus to lupus nephritis: The evolving road to targeted therapies. Autoimmunity Reviews. 22(10). 103404–103404. 27 indexed citations

Augé, Josep M., Andrés Ponce, Juan Camilo Sarmiento-Monroy, et al.. (2023). Calprotectin in Patients with Rheumatic Immunomediated Adverse Effects Induced by Checkpoints Inhibitors. Cancers. 15(11). 2984–2984. 2 indexed citations

10.

Pérez‐Pampín, Eva, María J. Gómara, Juan Camilo Sarmiento-Monroy, et al.. (2023). Assessment of anti-malondialdehyde-acetaldehyde antibody frequencies in rheumatoid arthritis with new data from two independent cohorts, meta-analysis, and meta-regression. Arthritis Research & Therapy. 25(1). 192–192.

11.

Vanegas-García, Adriana Lucía, et al.. (2023). Relevance of non-criteria antiphospholipid antibodies titers among patients with antiphospholipid syndrome and patients with systemic lupus erythematosus. Reumatología Clínica (English Edition). 19(4). 197–203. 2 indexed citations

12.

Betancur, Juan Felipe, et al.. (2022). Bilateral striopallidal calcinosis secondary to systemic lupus erythematosus. SHILAP Revista de lepidopterología. 17(6). 2257–2261.

13.

Ponce, Andrés, J. Inciarte-Mundo, Rosa Morlà, et al.. (2022). Plasma calprotectin as a biomarker of ultrasound synovitis in rheumatoid arthritis patients receiving IL-6 antagonists or JAK inhibitors. Therapeutic Advances in Musculoskeletal Disease. 14. 1759720X221114105–1759720X221114105. 5 indexed citations

14.

Ruíz-Esquide, Virginia, et al.. (2022). Complete disappearance of pulmonary rheumatoid nodules after long term rituximab treatment: case report. Rheumatology International. 43(3). 533–536. 1 indexed citations

15.

Castellanos‐Moreira, Raúl, S. C. Rodriguez-García, María J. Gómara, et al.. (2020). Anti-carbamylated proteins antibody repertoire in rheumatoid arthritis: evidence of a new autoantibody linked to interstitial lung disease. Annals of the Rheumatic Diseases. 79(5). 587–594. 54 indexed citations

16.

Gómez‐Puerta, José A., Luis Fernando Arias, Catalina Burbano, et al.. (2016). Infiltrating CD16⁺Are Associated with a Reduction in Peripheral CD14⁺CD16⁺⁺Monocytes and Severe Forms of Lupus Nephritis. Autoimmune Diseases. 2016. 1–7. 19 indexed citations

17.

Gómez‐Puerta, José A., Gerard Espinosa, & Ricard Cervera. (2016). Antiphospholipid Antibodies: From General Concepts to Its Relation with Malignancies. Antibodies. 5(3). 18–18. 13 indexed citations

18.

Gifre, Laia, Virginia Ruíz-Esquide, Antoni Xaubet, et al.. (2010). Sarcoidosis pulmonar inducida por antagonistas del factor de necrosis tumoral en la artritis reumatoide: presentación de un caso y revisión de la literatura médica. Archivos de Bronconeumología. 47(4). 208–212. 26 indexed citations

19.

Gómez‐Puerta, José A. & Ricard Cervera. (2008). Lupus eritematoso sistémico. Dialnet (Universidad de la Rioja). 14. 211–223. 8 indexed citations

20.

Sanmartí, Raimón, Guadalupe Ercilla, M. Larrosa, et al.. (2006). Prognostic factors of radiographic progression in early rheumatoid arthritis: a two year prospective study after a structured therapeutic strategy using DMARDs and very low doses of glucocorticoids. Clinical Rheumatology. 26(7). 1111–1118. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact